Cysteamine induces duodenal ulcer in the mouse

Area of Science:

• Gastroenterology
• Pharmacology

Background:

• Duodenal ulcer disease affects millions globally.
• Existing animal models have limitations in fully replicating human pathophysiology.

Purpose of the Study:

• To develop and characterize a novel mouse model for duodenal ulcer disease.
• To assess the utility of this model for screening antiulcerogenic compounds.

Main Methods:

• Induction of duodenal ulcers in mice via oral or subcutaneous administration of cysteamine.
• Dose- and time-response analysis of cysteamine-induced ulceration.
• Assessment of gastric acidity and pepsin activity.
• Evaluation of protective effects of lergotrile and cimetidine.

Main Results:

• Cysteamine reliably induced duodenal ulcers in a time- and dose-dependent manner.
• The mouse model exhibited similarities to rat and human ulcer disease.
• Gastric acidity and pepsin activity were significantly increased by cysteamine.
• Lergotrile and cimetidine demonstrated protective effects against ulcer formation.

Conclusions:

• A new, reliable mouse model for duodenal ulcer disease has been established.
• This model offers a valuable platform for studying ulcer pathogenesis.
• The model is suitable for cost-effective screening of novel antiulcerogenic drugs.